These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 9072885

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [The role of iron deficiency on the development of anemia in patients on regular dialysis therapy].
    Zadrazil J, Papajík T, Bachleda P, Budíková M, Novotný D, Scudla V.
    Vnitr Lek; 1994 Jun; 40(6):362-6. PubMed ID: 8073646
    [Abstract] [Full Text] [Related]

  • 23. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
    Attallah N, Osman-Malik Y, Frinak S, Besarab A.
    Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The role of high-dose oral iron supplementation during erythropoietin therapy for anemia of prematurity.
    Bader D, Kugelman A, Maor-Rogin N, Weinger-Abend M, Hershkowitz S, Tamir A, Lanir A, Attias D, Barak M.
    J Perinatol; 2001 Jun; 21(4):215-20. PubMed ID: 11533837
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The efficiency of fractionated parenteral iron treatment in CAPD patients.
    Akcicek F, Ozkahya M, Cirit M, Ok E, Unsal A, Toz H, Celik A, Atabay G, Basci A.
    Adv Perit Dial; 1997 Jun; 13():109-12. PubMed ID: 9360661
    [Abstract] [Full Text] [Related]

  • 28. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V, Nuzziello M, Pallotta G, Sacchetti A, Petrarulo F.
    J Nephrol; 2000 Jun; 13(6):444-9. PubMed ID: 11132761
    [Abstract] [Full Text] [Related]

  • 29. Comparison of parenteral iron sucrose and ferric chloride during erythropoietin therapy of haemodialysis patients.
    Wu CJ, Lin HC, Lee KF, Chuang CK, Chen YC, Chen HH.
    Nephrology (Carlton); 2010 Feb; 15(1):42-7. PubMed ID: 20377770
    [Abstract] [Full Text] [Related]

  • 30. [Can anemia be corrected in hemodialysis patients with thalassaemia minor? ].
    Di Iorio B, Guastaferro P, Gironda A, Marano V, Morrongiello L, Cillo N, Zito B, Nigro F, Frieri A, Rubino R, Bellizzi V.
    G Ital Nefrol; 2002 Feb; 19(5):552-9. PubMed ID: 12439845
    [Abstract] [Full Text] [Related]

  • 31. Erythropoietin requirements: a comparative multicenter study between peritoneal dialysis and hemodialysis.
    Coronel F, Herrero JA, Montenegro J, Fernandez C, Gandara A, Conesa J, Rivera MT, Torrente J, Portolés J, Gomez-Martino JR.
    J Nephrol; 2003 Feb; 16(5):697-702. PubMed ID: 14733416
    [Abstract] [Full Text] [Related]

  • 32. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
    Arndt U, Kaltwasser JP, Gottschalk R, Hoelzer D, Möller B.
    Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
    [Abstract] [Full Text] [Related]

  • 33. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
    Pela I, Lavoratti GC, Materassi M, Burgio G, Bartolozzi G.
    Pediatr Med Chir; 1991 Mar; 13(5):475-7. PubMed ID: 1788107
    [Abstract] [Full Text] [Related]

  • 34. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
    Acharya VN, Sinha DK, Almeida AF, Pathare AV.
    J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
    Reuter SE, Faull RJ, Ranieri E, Evans AM.
    Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
    [Abstract] [Full Text] [Related]

  • 38. Comparative response to single or divided doses of parenteral iron for functional iron deficiency in hemodialysis patients receiving erythropoietin (EPO).
    Saltissi D, Sauvage D, Westhuyzen J.
    Clin Nephrol; 1998 Jan; 49(1):45-8. PubMed ID: 9491286
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A randomized trial of three iron dextran infusion methods for anemia in EPO-treated dialysis patients.
    Auerbach M, Winchester J, Wahab A, Richards K, McGinley M, Hall F, Anderson J, Briefel G.
    Am J Kidney Dis; 1998 Jan; 31(1):81-6. PubMed ID: 9428456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.